本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Lyra Therapeutics

0.1083
-0.0032-2.87%
盘后0.11290.0046+4.25%19:55 EDT
成交量:141.48万
成交额:15.72万
市值:713.48万
市盈率:-0.08
高:0.1150
开:0.1127
低:0.1074
收:0.1115
数据加载中...
2024/05/21

重要事件披露

Form 8-K - Current report
2024/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/30

重要事件披露

Form 8-K - Current report
2024/04/19

重要事件披露

Form 8-K - Current report
2024/03/28

SEC问询函

Form CORRESP - Correspondence
2024/03/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/28

重要事件披露

Form 8-K - Current report
2023/12/19

重要事件披露

Form 8-K - Current report
2023/11/17

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/07

重要事件披露

Form 8-K - Current report